investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
Brett Stewart Carver
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Brett Stewart Carver
Memorial Sloan Kettering Cancer Center
New York, United States
Related projects
Paul Tempst
Immobilized protease activity tests for developing functional cancer biomarkers.
Prostate
Michael Bustin
Biological Functions of Chromosomal Proteins
Prostate
Pediatric oncology or childhood cancer
Radiation Oncology
Charles L. Sawyers
Understanding Resistance to Next Generation Antiandrogens
Prostate
Fredrick R Schumacher
Imputation-Based Approach to Identify Low Frequency Variants in Prostate Cancer
Prostate
Pathology
Li Xin
The Notch Signaling in Prostate Homeostasis and Carcinogenesis
Prostate
Sue-Hwa Lin
Bone Microenvironment on Dormancy of Metastatic Prostate Cancer Cells
Prostate
Pathology
Anne E Cress
Human Prostate Cancer Metastasis and Laminin Binding Integrins
Prostate
Pathology
Yan Xu
Role of immune cell OGR1 in prostate cancer development and the mechanisms involv
Prostate
Pathology
Mark Lewandoski
The Role of Fgf Signaling in Vertebrate DevelopmentĀ
Prostate